Smith & Nephew set to reap rewards of investment in sales force
This article was originally published in Clinica
Executive Summary
UK orthopaedics group Smith & Nephew expects to continue growing faster than its peers in 2005, as it feels the benefits of the recent expansion and focusing of its sales forces, and of its strong product portfolio. Chief executive Sir Christopher O'Donnell told Clinica the company was in a good position to achieve overall sales growth of 12-13% (excluding currency effects) in 2005.